We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Accept Cookies
Determining the origin and identity of particulate matter in (bio)pharmaceutical drug products is crucial for troubleshooting and root-cause analysis and, thus, often very time-critical. The identification approach includes the visual inspection of the sample inside the primary container, a high-resolution photo documentation of the particles and a subsequent identification of the isolated particles by a range of specialized analytical techniques, including FTIR microscopy, SEM-EDX and Raman.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy